SCHEMBL5151972

SCHEMBL5151972

NS(=O)(=O)c1ncccc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 3/20 0.56
KDM4E B2RXH2 5/20 0.55
TDP1 Q9NUW8 1/20 0.55
ALDH1A1 P00352 7/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
ALOX15 P16050 2/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
TSHR P16473 1/20 0.53
BLM P54132 1/20 0.53
AGER Q15109 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
LMNA P02545 2/20 0.52
ALOX12 P18054 1/20 0.45
DHODH Q02127 2/20 0.45
KDM6B O15054 1/20 0.45
KDM6A O15550 1/20 0.45
TET3 O43151 1/20 0.45
KDM4A O75164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2213767 0.85 PARP1 (0.51) NAPRTKDM4ETDP1ALDH1A1L3MBTL1
SCHEMBL21449055 0.83 KDM4E (0.57) NAPRTKDM4ETDP1ALDH1A1L3MBTL1
SCHEMBL31368527 0.81 KDM4E (0.55) NAPRTKDM4ETDP1ALDH1A1L3MBTL1
SCHEMBL9826240 0.81 LMNA (0.56) NAPRTKDM4ETDP1ALDH1A1L3MBTL1
SCHEMBL8629880 0.80 CA1 (0.57) KDM4ETDP1ALDH1A1L3MBTL1TSHR
SCHEMBL2705046 0.80 P2RX7 (0.41) NAPRTKDM4ETDP1ALDH1A1L3MBTL1
SCHEMBL9363595 0.80 P2RX7 (0.49) NAPRTLMNAP2RX7CA1CA2
SCHEMBL6479557 0.79 KMT2A (0.54) NAPRTKDM4ETDP1ALDH1A1L3MBTL1
SCHEMBL27310244 0.77 KDM4E (0.50) NAPRTKDM4ETDP1ALDH1A1L3MBTL1
SCHEMBL8537341 0.76 FTO (0.49) KDM4ETDP1ALDH1A1L3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113248427-B Sulfonyl nicotinic acid derivative, amido nicotinic acid derivative, preparation method and application thereof 苏州大学 2023-05-02 CN disclosed
CN-113248427-B Sulfonyl nicotinic acid derivative, amido nicotinic acid derivative, preparation method and application thereof 苏州大学 2023-05-02 CN disclosed
EP-2970296-B1 PYRROLOTRIAZINES AS POTASSIUM ION CHANNEL INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2016-12-21 EP disclosed
EP-2970296-A1 PYRROLOTRIAZINES AS POTASSIUM ION CHANNEL INHIBITORS Bristol-Myers Squibb Company (US) 2016-01-20 EP disclosed
US-9050345-B2 Pyrrolotriazines as potassium ion channel inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2015-06-09 US disclosed
WO-2014143610-A1 PYRROLOTRIAZINES AS POTASSIUM ION CHANNEL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-09-18 WO disclosed
US-20140256719-A1 PYRROLOTRIAZINES AS POTASSIUM ION CHANNEL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2014-09-11 US disclosed
US-20070135399-A1 Heteroaromatic sulphonamide prodrugs BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-14 US disclosed
US-5512535-A PRE- AND POSTEMERGENCE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1996-04-30 US disclosed
EP-0165753-B1 HERBICIDAL THIOPHENESULFONAMIDES AND PYRIDINESULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-12-11 EP disclosed
EP-0314302-A2 Herbicidal o-carbomethoxy-sulfonylureas E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-05-03 EP disclosed
WO-1989002700-A2 HERBICIDAL O-CARBOMETHOXYSULFONYLUREAS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-04-06 WO disclosed
US-4784684-A Herbicidal pyridinesulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-11-15 US disclosed
US-4668279-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-05-26 US disclosed
EP-0165753-A2 Herbicidal thiophenesulfonamides and pyridinesulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135399-A1 Heteroaromatic sulphonamide prodrugs SULT2A1, SULT1E1, SULT1A1 NAPRT 79/4885KDM4E 1199/4885TDP1 1762/4885
US-20140256719-A1 PYRROLOTRIAZINES AS POTASSIUM ION CHANNEL INHIBITORS KCNJ4, KCNJ2, KCNA4 NAPRT 1471/4885KDM4E 1004/4885TDP1 2842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.